Mary Mosher

Array ( [id] => 3758353 [patent_doc_number] => 05843733 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-01 [patent_title] => 'Synthesis and immunogenicity of rotavirus genes using a baculovirus expression system' [patent_app_type] => 1 [patent_app_number] => 8/485575 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8935 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/843/05843733.pdf [firstpage_image] =>[orig_patent_app_number] => 485575 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3796132 [patent_doc_number] => 05827696 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-27 [patent_title] => 'Synthesis and immunogenicity of rotavirus genes using a baculovirus expression system' [patent_app_type] => 1 [patent_app_number] => 8/475907 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8937 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/827/05827696.pdf [firstpage_image] =>[orig_patent_app_number] => 475907 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4021500 [patent_doc_number] => 05925546 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-20 [patent_title] => 'Immunologically active polypeptides with altered toxicity useful for the preparation of an antipertussis vaccine' [patent_app_type] => 1 [patent_app_number] => 8/478714 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6793 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 197 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/925/05925546.pdf [firstpage_image] =>[orig_patent_app_number] => 478714 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3784891 [patent_doc_number] => 05840541 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-24 [patent_title] => 'Synthesis and immunogenicity of rotavirus genes using a baculovirus expression system' [patent_app_type] => 1 [patent_app_number] => 8/485577 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8938 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/840/05840541.pdf [firstpage_image] =>[orig_patent_app_number] => 485577 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4018650 [patent_doc_number] => 05925358 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-20 [patent_title] => 'Recombinant fowlpox viruses and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/484575 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 34193 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/925/05925358.pdf [firstpage_image] =>[orig_patent_app_number] => 484575 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3937527 [patent_doc_number] => 05871998 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-16 [patent_title] => 'Self-assembling recombinant papillomavirus capsid proteins' [patent_app_type] => 1 [patent_app_number] => 8/472678 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8852 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/871/05871998.pdf [firstpage_image] =>[orig_patent_app_number] => 472678 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3811383 [patent_doc_number] => 05709996 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-20 [patent_title] => 'Self-assembling recombinant papillomavirus capsid proteins' [patent_app_type] => 1 [patent_app_number] => 8/472673 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8852 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/709/05709996.pdf [firstpage_image] =>[orig_patent_app_number] => 472673 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4105097 [patent_doc_number] => 06022685 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-08 [patent_title] => 'Methods and compositions for detecting anti-hepatitis E virus activity' [patent_app_type] => 1 [patent_app_number] => 8/484819 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14182 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/022/06022685.pdf [firstpage_image] =>[orig_patent_app_number] => 484819 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3920856 [patent_doc_number] => 05914123 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-22 [patent_title] => 'Vaccines expressed in plants' [patent_app_type] => 1 [patent_app_number] => 8/479742 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 18332 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/914/05914123.pdf [firstpage_image] =>[orig_patent_app_number] => 479742 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4011312 [patent_doc_number] => 05889172 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-30 [patent_title] => 'DNA sequences for immunologically active peptides of pertussis toxin' [patent_app_type] => 1 [patent_app_number] => 8/479626 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6797 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/889/05889172.pdf [firstpage_image] =>[orig_patent_app_number] => 479626 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5828494 [patent_doc_number] => 20020068326 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-06 [patent_title] => 'PAPILLOMAVIRUS VACCINES' [patent_app_type] => new [patent_app_number] => 08/473228 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12136 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20020068326.pdf [firstpage_image] =>[orig_patent_app_number] => 08473228 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3741255 [patent_doc_number] => 05716620 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-10 [patent_title] => 'Self-assembling recombinant papillomavirus capsid proteins' [patent_app_type] => 1 [patent_app_number] => 8/475783 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8844 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/716/05716620.pdf [firstpage_image] =>[orig_patent_app_number] => 475783 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4067557 [patent_doc_number] => 06008326 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-28 [patent_title] => 'Transferrin receptor antibodies' [patent_app_type] => 1 [patent_app_number] => 8/474671 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 140 [patent_figures_cnt] => 35 [patent_no_of_words] => 73528 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/008/06008326.pdf [firstpage_image] =>[orig_patent_app_number] => 474671 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4080338 [patent_doc_number] => 06162461 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-19 [patent_title] => 'Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor' [patent_app_type] => 1 [patent_app_number] => 8/482161 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 16781 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/162/06162461.pdf [firstpage_image] =>[orig_patent_app_number] => 482161 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4286107 [patent_doc_number] => 06268213 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-31 [patent_title] => 'Adeno-associated virus vector and cis-acting regulatory and promoter elements capable of expressing at least one gene and method of using same for gene therapy' [patent_app_type] => 1 [patent_app_number] => 8/475470 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 44 [patent_no_of_words] => 19347 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/268/06268213.pdf [firstpage_image] =>[orig_patent_app_number] => 475470 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3905706 [patent_doc_number] => 06001369 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-14 [patent_title] => 'Recombinant fowlpox viruses and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/477459 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 33746 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/001/06001369.pdf [firstpage_image] =>[orig_patent_app_number] => 477459 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3597402 [patent_doc_number] => 05559014 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-09-24 [patent_title] => 'Methods and reagents to detect and characterize Norwalk and related viruses' [patent_app_type] => 1 [patent_app_number] => 8/485576 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3216 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/559/05559014.pdf [firstpage_image] =>[orig_patent_app_number] => 485576 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3992030 [patent_doc_number] => 05985610 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-16 [patent_title] => 'Self-assembling recombinant papillomavirus capsid proteins' [patent_app_type] => 1 [patent_app_number] => 8/484503 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11130 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/985/05985610.pdf [firstpage_image] =>[orig_patent_app_number] => 484503 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4115149 [patent_doc_number] => 06046169 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-04 [patent_title] => 'Inhibitors of factor XA' [patent_app_type] => 1 [patent_app_number] => 8/486386 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18257 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 433 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/046/06046169.pdf [firstpage_image] =>[orig_patent_app_number] => 486386 [rel_patent_id] =>[rel_patent_doc_number] =>)